05:56 PM EDT, 10/07/2024 (MT Newswires) -- Greenwich LifeSciences ( GLSI ) filed a registration statement Monday with the US Securities and Exchange Commission for the potential sale of securities from time to time in one or more offerings, with an aggregate initial offering price not exceeding $275 million.

The prospectus covers the sale of common stock, preferred stock, debt securities, warrants and units.

The company said it plans to use the proceeds for general corporate purposes.

Shares of Greenwich fell 3.3% in after-hours activity.

Price: 13.17, Change: -0.45, Percent Change: -3.30